by | Oct 22, 2019 | Huang, Li-Hao, Randolph, Gwendalyn, Zinselmeyer, Bernd
— Background
High-density lipoproteins (HDLs) have been widely studied and linked to various diseases, especially metabolic diseases. HDL levels in the blood have traditionally been used as a benchmark for risk of cardiovascular disease. However, these blood tests may be misleading – HDL levels…
by | Oct 22, 2019 | Jiang, Xuntian, Ory, Daniel
— Background
Gaucher and Krabbe disease are two types of lipid (fat) storage diseases that can result in progressive damage to the nervous system and other organ systems. Together, these diseases affect about 450,000 people worldwide. In both of these diseases, there is an undesirable accumulation of…
by | Oct 22, 2019 | Stahl, Philip
— Technology Description: The mannose receptor is uniquely found on macrophages and not on monocytes, making the mannose receptor a target for macrophage activation. Researchers at Washington University have developed polypeptide backbones to target the mannose receptor on macrophages. This technology…
by | Oct 22, 2019 | Guruswami, Sundaram, Sharma, Vijay, Sivapackiam, Jothilingam
— Background
Frontotemporal Dementia (FTD) is the second most common form of non-Alzheimer’s dementia in the population under 65 years old. FTD represents approximately 20% of all dementias and onset normally appears in the mid to late 50s. Clinically FTD is characterized by a progressive neur…
by | Oct 22, 2019 | Bieschke, Jan, Guruswami, Sundaram, Liu, Yongjian, Sharma, Vijay
— Background
8 million people per year are diagnosed with light-chain (AL) amyloidosis, a progressive disease than can quickly affect the kidney, heart, and nervous system if left untreated. The current method of diagnosis involves histological confirmation via biopsies of bone marrow, fat, and organ…